Compare Natco Pharma with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs SUVEN LIFESCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA SUVEN LIFESCIENCES NATCO PHARMA/
SUVEN LIFESCIENCES
 
P/E (TTM) x 23.2 4.3 538.5% View Chart
P/BV x 3.5 0.6 544.3% View Chart
Dividend Yield % 1.0 3.6 27.0%  

Financials

 NATCO PHARMA   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-19
SUVEN LIFESCIENCES
Mar-19
NATCO PHARMA/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs849338 251.4%   
Low Rs557169 328.8%   
Sales per share (Unadj.) Rs573.852.1 1,100.8%  
Earnings per share (Unadj.) Rs176.06.8 2,576.6%  
Cash flow per share (Unadj.) Rs198.28.6 2,312.6%  
Dividends per share (Unadj.) Rs6.251.50 416.7%  
Dividend yield (eoy) %0.90.6 150.3%  
Book value per share (Unadj.) Rs842.765.3 1,290.8%  
Shares outstanding (eoy) m36.50127.28 28.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.24.9 25.2%   
Avg P/E ratio x4.037.1 10.8%  
P/CF ratio (eoy) x3.529.6 12.0%  
Price / Book Value ratio x0.83.9 21.5%  
Dividend payout %3.622.0 16.2%   
Avg Mkt Cap Rs m25,66032,272 79.5%   
No. of employees `0005.01.1 458.1%   
Total wages/salary Rs m3,559661 538.3%   
Avg. sales/employee Rs Th4,225.36,132.2 68.9%   
Avg. wages/employee Rs Th718.0611.1 117.5%   
Avg. net profit/employee Rs Th1,295.9803.5 161.3%   
INCOME DATA
Net Sales Rs m20,9456,635 315.7%  
Other income Rs m1,302242 537.4%   
Total revenues Rs m22,2476,877 323.5%   
Gross profit Rs m7,9481,604 495.4%  
Depreciation Rs m810221 365.9%   
Interest Rs m19338 511.9%   
Profit before tax Rs m8,2471,587 519.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,823718 253.9%   
Profit after tax Rs m6,424869 738.9%  
Gross profit margin %37.924.2 156.9%  
Effective tax rate %22.145.2 48.9%   
Net profit margin %30.713.1 234.1%  
BALANCE SHEET DATA
Current assets Rs m23,4726,232 376.6%   
Current liabilities Rs m7,2871,490 489.0%   
Net working cap to sales %77.371.5 108.1%  
Current ratio x3.24.2 77.0%  
Inventory Days Days9286 106.7%  
Debtors Days Days8883 106.8%  
Net fixed assets Rs m18,6484,043 461.2%   
Share capital Rs m365127 286.7%   
"Free" reserves Rs m34,5258,183 421.9%   
Net worth Rs m30,7608,310 370.2%   
Long term debt Rs m018 0.0%   
Total assets Rs m43,03110,389 414.2%  
Interest coverage x43.743.1 101.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.6 76.2%   
Return on assets %15.48.7 176.1%  
Return on equity %20.910.5 199.6%  
Return on capital %27.419.5 140.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m11,5365,622 205.2%   
Fx outflow Rs m2,9391,799 163.3%   
Net fx Rs m8,5973,822 224.9%   
CASH FLOW
From Operations Rs m6,688356 1,881.3%  
From Investments Rs m-6,122-279 2,197.4%  
From Financial Activity Rs m-509-225 226.1%  
Net Cashflow Rs m66-148 -44.5%  

Share Holding

Indian Promoters % 52.0 63.4 82.1%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 0.0 -  
FIIs % 16.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 36.5 71.2%  
Shareholders   25,395 37,287 68.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   WOCKHARDT  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  BIOCON   FULFORD INDIA  

Compare NATCO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 429 Points Higher; Auto and IT Stocks Rally(Closing)

Indian share markets extended gains for the second consecutive day and ended on a strong note, tracking gains in Asian peers and Wall Street.

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

This is How You Should Trade Intraday(Fast Profits Daily)

Jun 19, 2020

In this video, I'll show you how to trade the market intraday like a professional trader.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jul 2, 2020 03:35 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - WOCKHARDT COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS